The <scp>NLRP1</scp> Emerges as a Promising Therapeutic Target and Prognostic Biomarker Across Multiple Cancer Types: A Comprehensive Pan‐Cancer Analysis
Reduced NLRP1 expression contributes to cancer progression and holds potential as a crucial biomolecular marker for diagnostic, prognostic, and personalized therapeutic interventions across different malignancies.
Authors
- Amirhossein Mohajeri Khorasani (ORCID: https://orcid.org/0000-0002-3730-6009)
- Leila Habibipour
- Pegah Mousavi (ORCID: https://orcid.org/0000-0002-5654-7561)
- Mahboubeh Sadeghi (ORCID: https://orcid.org/0000-0002-4577-6000)
- Nima Sanadgol (ORCID: https://orcid.org/0000-0002-4509-5336)
- Alireza Raghibi (ORCID: https://orcid.org/0009-0001-6731-419X)
Institutions
- Mashhad University of Medical Sciences (IR)
- Universitätsklinikum Aachen (DE)
- Hormozgan University of Medical Sciences (IR)
- Tehran University of Medical Sciences (IR)
- RWTH Aachen University (DE)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1002/cam4.70836
- Citations
- 2
- Primary Topic
- Inflammasome and immune disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.61